ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学術雑誌論文等

Soluble receptor for advanced glycation end-products and progression of airway disease

https://hiroshima.repo.nii.ac.jp/records/2006519
https://hiroshima.repo.nii.ac.jp/records/2006519
dc60a8ff-c72c-4707-8062-925918466fae
名前 / ファイル ライセンス アクション
Bmcpm_14_68.pdf Bmcpm_14_68.pdf (334.6 KB)
Item type デフォルトアイテムタイプ_(フル)(1)
公開日 2023-03-18
タイトル
タイトル Soluble receptor for advanced glycation end-products and progression of airway disease
言語 en
作成者 Iwamoto, Hiroshi

× Iwamoto, Hiroshi

en Iwamoto, Hiroshi

Search repository
Gao, Jing

× Gao, Jing

en Gao, Jing

Search repository
Pulkkinen, Ville

× Pulkkinen, Ville

en Pulkkinen, Ville

Search repository
Tuula, Toljamo

× Tuula, Toljamo

en Tuula, Toljamo

Search repository
Nieminen, Pentti

× Nieminen, Pentti

en Nieminen, Pentti

Search repository
Mazur, Witold

× Mazur, Witold

en Mazur, Witold

Search repository
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
権利情報
権利情報 © 2014 Iwamoto et al.; licensee BioMed Central Ltd. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
内容記述
内容記述 Background: The receptor for advanced glycation end-products (RAGE) is highly expressed in the lung, where it is believed to have a homeostatic role. Reduced plasma levels of soluble RAGE (sRAGE) have been reported in patients with chronic obstructive pulmonary disease (COPD). The aim of the present study was to evaluate the association of plasma sRAGE levels with a longitudinal decline of lung function. We have also measured plasma levels of high mobility group box 1 (HMGB1), a RAGE ligand which has been associated with chronic inflammatory diseases including COPD. Methods: Baseline plasma concentrations of sRAGE and HMGB1 were measured in non-smokers (n = 32), smokers without COPD (n = 212), and smokers with COPD (n = 51), and the associations of the plasma sRAGE and HMGB1 levels with longitudinal declines of lung function during a 4-year follow-up period were analysed. Results: The plasma levels of sRAGE were significantly lower in smokers without COPD and in smokers with COPD, as compared to those of non-smokers. Plasma sRAGE levels positively correlated with FVC and FEV1 and inversely correlated with BMI and pack-years. Lower sRAGE levels were associated with greater declines of FEV1/FVC over 4 years in all participants. Moreover, multivariate regression analysis indicated that the baseline plasma sRAGE concentration was an independent predictor of FEV1/FVC decline in all groups. A subgroup analysis showed that decreased sRAGE levels are significantly associated with a more rapid decline of FEV1/FVC in smokers with COPD. There was no significant correlation between plasma HMGB1 levels and longitudinal decline of lung function. Conclusions: Lower plasma concentrations of sRAGE were associated with greater progression of airflow limitations over time, especially in smokers with COPD, suggesting that RAGE might have a protective role in the lung.
言語 en
内容記述
内容記述タイプ Other
内容記述 This work was financially supported by the EVO funding of the Helsinki University Central Hospital, Research Funds of the University of Helsinki, Finnish Anti-tuberculosis Association Foundation, and partly by the SalWe Research program for IMO (Tekes - the Finnish Funding Agency for Technology and Innovation grant 648/10). Jing Gao is further supported by the China Scholarship Council (CSC), CIMO, and HES-Foundation.
出版者
出版者 BioMed Central Ltd.
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
関連情報
識別子タイプ DOI
関連識別子 10.1186/1471-2466-14-68
関連情報
識別子タイプ PMID
関連識別子 24758342
関連情報
識別子タイプ DOI
関連識別子 https://doi.org/10.1186/1471-2466-14-68
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 1471-2466
開始ページ
開始ページ 68
書誌情報 BMC Pulmonary Medicine
BMC Pulmonary Medicine

巻 14, p. 68, 発行日 2014-04-24
旧ID 48655
戻る
0
views
See details
Views

Versions

Ver.1 2025-02-21 03:23:49.130308
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3